Introduction
Prostaglandins, a group of specialized hydroxy-fatty acids, have been shown to possess spasmogenic effects on human non-pregnant (Pickles et al., 1965) and pregnant myometrium (Embrey and Morrison, 1968) . Bygdeman et al. (1968) showed that the E prostaglandins caused "unphysiological elevation of tonus" and thought that they were unsuitable for the induction of labour. More recently, however, they have been used successfully to induce labour at or near term, without hypertonus (Embrey, 1970; Karim et al., 1970) . As relatively few centres are investigating the clinical applications of prostaglandin administration, the experience in Cardiff is presented of the intravenous infusion of prostaglandins F2a, E2, and E, for induction of labour, with particular emphasis on the incidence of uterine hypertonus during administration of prostaglandin E2.
Patients and Methods
Patients chosen for study were those in whom induction of labour was required because of the obstetric conditions shown in the Table. The state of the cervix was assessed and classified according to the criteria of Embrey and Anselmo (1962) . After amniotomy the uterine activity was recorded by measuring intra-amniotic pressure changes by means of an open-ended saline-filled catheter inserted into the uterus with the aid of a modified Drew Smythe catheter. The fluid-filled catheter was then connected to a Sanborn 267 AC pressure stimulatory uterine effects after amniotomy alone were excluded from the study. The prostaglandins, which had been previously diluted in ethanol (0.5 mg/ml) and stored at -20°C, were further diluted with iso-osmotic saline before being administered by means of a Palmer continuous slow injector. The maternal pulse rate, blood pressure, and fetal heart rates were recorded frequently.
For prostaglandin F2cx an infusion rate of 3 ,g/min was used initially and doubled when necessary to obtain optimum uterine activity. In the earlier cases induced with prostaglandin E2 an initial infusion rate of 3 ,ug/min was also used, but with experience smaller doses were often found to be effective (0.75-1.5 ,ug/min). At first the infusions were usually continued until the patient delivered, but as the study progressed it was found that the infusion could be discontinued when labour was well established. The type of prostaglandin used in each individual was determined by its availability at the time rather than by random selection. Prostaglandin F2a was used in seven patients, E2 in 18, and E1 in 10.
In the group studied (see Table) 11 were primigravid patients and 13 were of parity 3 or greater. The physical state of the cervix was noted to be unfavourable in 10 cases intermediate in 19, and favourable in 6.
A constant feature of our intravenous infusion of prostaglandins has been the development of a "red line" over the course of the vein from the site of the cannula, and some patients have complained of severe pain in the forearm or shoulder on the same side as the infusion but distant from the cannula in the vein.
Results
Induction of labour was successful in 34 out of 35 cases; all patients successfully induced delivered within 13+ hours. The latent period between the start of the infusion and the onset of stimulated uterine activity ranged from 20 to 40 minutes with prostaglandin F2aC, but with the E prostaglandins the latent period was much shorter, about 10 minutes on average.
In agreement with the findings of other workers, E prostaglandins were found to be more potent oxytocics than F2a, and the E compounds could effectively induce labour in smaller doses than prostaglandin F2a. Of the 34 successful cases, 31 had spontaneous vaginal deliveries. Two patients required forceps deliveries for delay in the second stage of labour. In one patient (Case 6) a lower uterine segment caesarean section was considered desirable even at full dilatation of the cervix because she was a 39-year-old primigravida and the fetal head remained in high cavity. The single failure in the series was Case 7. H'-r cerv:x was only 2 cm dilated after infusion of prostaglandin F2ca for 18 hours; uterine activity was augmented by an oxytocin infusion as the prostaglandin supply had been exhausted. Two babies (from Cases 10 and 35) showed the respiratory distress syndrome, though both were of low birth weight. One patient (Case 9) had an atonic postpartum haemorrhage though this was her fifth pregnancy and there was a history of a similar haemorrhage in one of her previous pregnancies. Uterine hypertonus occurred in four cases during administration of prostaglandin E2.
Case 8.-This patient was an elderly primigravida in whom labour was induced at term. Owing to an error in adjusting the speed of the injector pump, an accidental overdose of prostaglandin E2 (18 tLg./min) was administered. Three minutes after starting the infusion she complained of intense continuous abdominal pain. Hvpertonus was suspected and the tracings confirmed the tetanic-like spasm of the uterus (50 mm Hg) the effect lasting for eight minutes (Fig. 1) . Immediately the hypertonus was recognized the infusion was stopped, and normal basal uterine tone (15 mm Hg) was restored within five minutes. During this time no abnormality of the fetal heart rate, maternal pulse, or blood pressure readings was noted. After an interval of 20 minutes the infusion was recommenced at a dose rate of 3 .g/min; normal uterine contractility was observed and the patient was delivered normally of a healthy baby 7 hours 35 minutes after amniotomy.
Case 13.-A 26-year-old gravida-2 had labour induced at term.
Prostaglandin E2 -was infused (1.5 ,ug/min). Ten minutes later the basal uterine tone rose to 30 -40 mm Hg (Fig. 2) for a period of eight minutes. Within five minutes of stopping the infusion normal basal uterine activity (15 mm Hg) was observed. The uterine hypertonus in this case was also recognized clinically.
Case 17.-Labour was induced in this patient at term because of pre-eclampsia. Successful induction was achieved at a dose rate of 1-5 ,ug/min; normal labour contractions were observed until 225 minstes of prostaglandin administration (Fig. 3) In none of the last three cases was there any alteration detected in fetal heart rates, maternal pulse rate, or blood pressure during the raised uterine tone.
Discussion
The results of this study show that after amniotomy routine intravenous infusion of prostaglandins is at least as effective as routine intravenous oxytocin titration used in the same way for the induction of labour. In this series of 35 cases the average induction interval of nine hours (eight hours for Eprostaglandins) was only slightly longer than the 7 hours 42 minutes reported by Francis et al. (1970) using automatic oxytocin "titration" after amniotomy. The percentage of patients who had an unfavourable cervix, or who were of parity 3 or more, was much higher in the prostaglandin series, however, and both these factors are known to increase the risks of BRITISH MEDICAL JOURNAL 27 MARCH 1971 induction failure (Turnbull and Anderson, 1968) . Induction with prostaglandins "failed" in only one case, but this was at least partly due to the supply being exhausted. These very satisfactory results confirm in general the work of Beazley et al. (1970) , Embrey (1970) , and Karim et al. (1970) .
Nevertheless the fact that potentially dangerous uterine hypertonus developed in four patients receiving prostaglandin E2 indicates that these compounds can readily cause hyperstimulation of the uterus, with its attendant possibilities of reduced placental blood flow and fetal hypoxia (CaldeyroBarcia and Poseiro, 1958) and even of uterine rupture. While the uterine hypertonus was certainly due to too high a dose in one patient, a rise in the resting uterine tone developed unexpectedly in the other three patients, at a dosage level well within the range used in other centres in this country.
A reassuring feature, however, was that in each of these episodes of hypertonus, the resting uterine tone was restored to normal within five minutes of stopping the infusion. Embrey (1969) showed that the oxytocic effect of prostaglandins may persist for 30 to 60 minutes after stopping the infusion and that in some cases there may be no diminution in uterine activity. Fortunately, this does not seem to apply when hypertonus develops during prostaglandin administration.
The first reports of the use of prostaglandin El and E2 in human pregnancy (Bygdeman et al., 1968) suggested that unphysiological rise in uterine tone was of frequent occurrence and that these compounds were unsuitable for induction of labour. Karim et al. (1970) pointed out, however, that in none of Bygdeman's cases had resting uterine tone been increased above 14 mm Hg, and went on to induce labour successfully in 50 patients, using intravenous infusion of prostaglandin E2 at a constant rate of 0.5 ,jg/min. No evidence of hypertonus was reported, and though the induction-delivery interval was prolonged over 18 hours in six cases (12%) amniotomy was not generally performed as a primary procedure. Beazley et al. (1970) varied the dose of prostaglandin E? to produce optimal uterine activity and noted one case in which transient hvpertonus occurred at an infusion rate of 40 ng/kg/min. Embrey (1970) , in a similar study on 25 patients, noted no hypertonus with prostaglandin E2 in doses between 0.5 and 8 ,ug/minr Work in Cardiff started before publication of these most recent reports, and prostaglandin Eo was used first in a dose of 3 ug/min, as being within the "threshold range" reported by Bygdeman et al. (1968) and Embrey (1969) . Experience quickly showed that lower doses of prostaglandin E2 should be used initially, and our practice now has been to begin with a dose of 0.75 ,ug/min and then double this, at intervals of two to four hours, if the uterine response is not satisfactory.
The Table shows (Roberts et al., 1970) , and they are also extremely effective within a much narrower dose range. On the other hand, a minor disadvantage of prostaglandin 705 infusion has been the constant development of what appears to be an "inflammatory reaction" in the arm vein.
Studies in the clinical uses of prostaglandins are still at an early stage. Prostaglandin metabolites or derivatives may give even better results than the compounds available at present. A plea is made that in future a standard description of dose rate will be adopted-",ug/min" seems simple and acceptable.
Rapid progress is being made, but the results reported here indicate that any future work on the uterus in late pregnancy must be very carefully monitored, by reliable measurement of amniotic fluid pressure, to detect any abnormal rise in uterine tone at the earliest possible moment.
We 
